---
layout: post
title: "Potential Medication Error Risks With Investigational Drug Container Labels; Public Meeting; Request for Comments"
date: 2026-02-05 19:08:49 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-05370
original_published: 2021-03-16 00:00:00 +0000
significance: 8.00
---

# Potential Medication Error Risks With Investigational Drug Container Labels; Public Meeting; Request for Comments

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** March 16, 2021 00:00 UTC
**Document Number:** 2021-05370

## Summary

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Potential Medication Error Risks with Investigational Drug Container Labels." This public meeting is being convened and supported by a partnership between the Reagan-Udall Foundation and FDA. The purpose of the public meeting is to solicit input from stakeholders (e.g., sponsors, clinical sites, entities that supply or otherwise label investigational drugs) on the risk of medication errors potentially related to the content and format of information on investigational drug container labels, the prevalence and nature of such errors, and to gather information on practices that minimize the potential for medication errors.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/03/16/2021-05370/potential-medication-error-risks-with-investigational-drug-container-labels-public-meeting-request)
- API: https://www.federalregister.gov/api/v1/documents/2021-05370

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
